Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other financing activities: 2021-2023

Historic Other financing activities for Journey Medical (DERM) over the last 1 years, with Dec 2023 value amounting to $380,000.

  • Journey Medical's Other financing activities rose 342.04% to $380,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.1 million, marking a year-over-year increase of 23.45%. This contributed to the annual value of $50,000 for FY2024, which is 89.38% down from last year.
  • Journey Medical's Other financing activities amounted to $380,000 in Q4 2023, which was up 342.04% from -$157,000 recorded in Q4 2022.
  • In the past 5 years, Journey Medical's Other financing activities ranged from a high of $1.4 million in Q1 2021 and a low of -$157,000 during Q4 2022.
  • For the 3-year period, Journey Medical's Other financing activities averaged around $431,667, with its median value being $375,500 (2022).
  • As far as peak fluctuations go, Journey Medical's Other financing activities crashed by 72.58% in 2022, and later surged by 342.04% in 2023.
  • Over the past 3 years, Journey Medical's Other financing activities (Quarterly) stood at $464,000 in 2021, then crashed by 72.58% to -$157,000 in 2022, then skyrocketed by 342.04% to $380,000 in 2023.
  • Its Other financing activities stands at $380,000 for Q4 2023, versus -$157,000 for Q4 2022 and $371,000 for Q1 2022.